Clinical trial
Janssen Asperger's MRS (Magnetic Resonance Spectroscopy Risperidone Study
NCT00352196 · Augusta University, Other · Completed
Key facts
| NCT number | NCT00352196 |
|---|---|
| Title | Janssen Asperger's MRS (Magnetic Resonance Spectroscopy Risperidone Study |
| Official title | A Biological Basis of Therapy for Negative Symptom Spectrum Disorders: Risperdal Effect on Frontal Metabolism in Asperger's Disorder |
| Lead sponsor | Augusta University, Other |
| Collaborators | Ortho-McNeil Janssen Scientific Affairs, LLC Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Asperger's Disorder |
| Intervention type | Drug, Other |
| Interventions | Risperidone, Magnetic Resonance Spectroscopy |
| Enrollment | 23 |
| Start date | Nov 1, 2001 |
| Primary completion | May 1, 2007 |
| Completion | May 1, 2007 |
| First posted | Jul 14, 2006 |
| Last update posted | Jan 14, 2015 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: